Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Inflammation, high-sensitivity C-reactive protein, and vascular protection.

Ridker PM.

Tex Heart Inst J. 2010;37(1):40-1. No abstract available.

2.

Impact of C-reactive protein on in-stent restenosis: a meta-analysis.

Li JJ, Ren Y, Chen KJ, Yeung AC, Xu B, Ruan XM, Yang YJ, Chen JL, Gao RL.

Tex Heart Inst J. 2010;37(1):49-57. Review.

3.

Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.

Momiyama Y, Ohmori R, Uto-Kondo H, Tanaka N, Kato R, Taniguchi H, Arakawa K, Nakamura H, Ohsuzu F.

J Atheroscler Thromb. 2011;18(2):108-14. Epub 2010 Nov 6.

4.

[Clinical value of inflammatory biomarkers after stent implantation].

Niccoli G, Montone RA, Ferrante G, Minelli S, Crea F.

G Ital Cardiol (Rome). 2011 Oct;12(10):635-44. doi: 10.1714/945.10348. Review. Italian.

PMID:
21947106
5.

Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.

Kang WC, Il Moon C, Lee K, Han SH, Suh SY, Moon J, Shin MS, Ahn T, Shin EK.

Coron Artery Dis. 2011 Dec;22(8):526-32. doi: 10.1097/MCA.0b013e32834bd946.

PMID:
21909023
6.

Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.

Rivero F, Benedicto A, Bastante T, Cuesta J, Diego G, Alfonso F.

EuroIntervention. 2015 Nov;11(7):780. doi: 10.4244/EIJY14M10_07. No abstract available.

7.

Platelets and endothelium: two key players in percutaneous coronary intervention.

Bonello L, Sabatier F, Camoin-Jau L, Paganelli F, Dignat-George F.

Arch Cardiovasc Dis. 2011 Dec;104(12):601-3. doi: 10.1016/j.acvd.2011.10.003. Epub 2011 Nov 18. No abstract available.

8.

Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty.

Parfyonova Y, Alekseeva I, Plekhanova O, Deev A, Titaeva E, Dobrovolsky A, Gabbasov Z, Lyakishev A, Tkachuk V.

Heart Vessels. 2014 Sep;29(5):611-8. doi: 10.1007/s00380-013-0407-1. Epub 2013 Sep 22.

PMID:
24057344
9.

Another small step for small vessels.

Morrison DA.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):67-9. doi: 10.1002/ccd.22686. No abstract available.

PMID:
20578195
10.

[Inflammatory response after coronary angioplasty - mechanisms and significance].

Koziński M, Kubica J.

Kardiol Pol. 2006 Jul;64(7):771-4; author reply 775. Polish. No abstract available.

11.

[Systemic markers of inflammation after coronary angioplasty].

Donal E, Allal J, Christiaens L, Lecron JC, Ragot S, Coisne D.

Presse Med. 2001 Nov 17;30(34):1701-5. Review. French.

PMID:
11760602
12.

Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.

Niccoli G, Ferrante G, Mongiardo R, Perfetti M, Belloni F, Burzotta F, Porto I, Leone AM, Rebuzzi AG, Crea F.

Cardiovasc Revasc Med. 2007 Jul-Sep;8(3):156-60.

PMID:
17765643
13.

Intracoronary optical diagnostics current status, limitations, and potential.

Lowe HC, Narula J, Fujimoto JG, Jang IK.

JACC Cardiovasc Interv. 2011 Dec;4(12):1257-70. doi: 10.1016/j.jcin.2011.08.015. Review.

14.

Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis.

Hognestad A, Endresen K, Wergeland R, Mellembakken JR, Mollnes TE, Omland T, Kjekshus JK, Aukrust P, Andreassen AK.

J Heart Lung Transplant. 2005 Aug;24(8):1026-32.

PMID:
16102437
15.

The relationships between serum C-reactive protein level and risk and progression of coronary and carotid atherosclerosis.

Stone PA, Kazil J.

Semin Vasc Surg. 2014 Dec;27(3-4):138-42. doi: 10.1053/j.semvascsurg.2015.04.002. Epub 2015 Apr 6. Review.

PMID:
26073821
16.

Drug-eluting stents: safe but not sufficient.

Vogel RA.

JACC Cardiovasc Interv. 2009 Jun;2(6):513-4. doi: 10.1016/j.jcin.2009.04.002. No abstract available.

17.

Postprocedural serum sLOX-1 levels are associated with coronary in-stent restenosis in patients with stable coronary artery disease.

Li B, Zhang LH, Yang XG, Liu Y, Liu XT, Ren YG.

Coron Artery Dis. 2011 Jun;22(4):259-63. doi: 10.1097/MCA.0b013e328344ede9.

PMID:
21346562
18.

Understanding the role of endothelial progenitor cells in cardiovascular disease, coronary artery lesion progression, and in-stent restenosis.

De Winter RJ, Klomp M.

JACC Cardiovasc Interv. 2010 Jan;3(1):87-9. doi: 10.1016/j.jcin.2009.11.006. No abstract available.

19.

The efficacy of drug-eluting stents in women: a window of opportunity.

Jacobs AK.

JACC Cardiovasc Interv. 2009 Jul;2(7):611-3. doi: 10.1016/j.jcin.2009.06.001. No abstract available.

20.

Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.

Mostowik M, Siniarski A, Gołębiowska-Wiatrak R, Nessler J, Gajos G.

Adv Clin Exp Med. 2015 Nov-Dec;24(6):979-85. doi: 10.17219/acem/46935.

Supplemental Content

Support Center